India to New Zealand: Losartan Export Trade Route

The India to New Zealand Losartan corridor is one of India's established pharmaceutical export routes, with 42 shipments documented worth a combined $5.1M USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 80% of all export value, reflecting the consolidated nature of India's losartan manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $121.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with losartan's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 17.2%, placing it at rank #10 among India's top losartan export destinations globally.

On the import side, key buyers of Indian losartan in New Zealand include NA, TEVA PHARMA (NEW ZEALAND) LIMITED , TO THE ORDER and 3 others. NA is the single largest importer with 18 shipments valued at $3.8M USD.

India's losartan exports to New Zealand are driven primarily by a handful of large-scale manufacturers. IPCA LABORATORIES LIMITED with 28 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in New Zealand benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — IPCA LABORATORIES LIMITED, IPCA LABORATORIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $121.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as losartan actavis?12.5 mg tablets(losartan potassium tablets 12.5mg(8880x6x14's pack=745920 tablets) and harmless medicines:losartan potassium 50 , suggesting that buyers in New Zealand tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NA is the largest importer with 18 shipments worth $3.8M USD — representing 75% of all losartan imports from India on this route. A total of 6 buyers are active on this corridor.